€100M round led by Index Ventures with participation from Greenoaks, Kaaf, SH, angels including Tobi Lütke and Antoine Griezmann, and corporate partner Belfius. Company reported €785,000,000 ARR in 2025, aiming for $1.16B ARR in 2026. Alan declared operational profitability in France and has reduced losses; net losses were $61M in 2023 and $56M in 2024.
About Alan
Paris-based digital health company combining health insurance, digital care, and preventive tools in one app to simplify reimbursements, care access, and personalised prevention.
Paris, France
Read Company ProfileFrequently Asked Questions
What type of funding round did Alan raise?
Alan raised a series-e+ round.
How much did Alan raise in its series-e+?
Alan raised $100,000,000 EUR in its series-e+.
When did Alan raise its series-e+?
Alan raised its series-e+ on 2026-03-11.
What was Alan's valuation after the series-e+?
Alan was valued at $5,000,000,000 EUR after the series-e+.
Who invested in Alan's series-e+?
The investors in Alan's series-e+ are: Index Ventures, Greenoaks, Kaaf, SH, Tobi Lütke, Antoine Griezmann, Belfius.
What type of investment was Alan's series-e+?
Alan's series-e+ was a equity investment.
How will Alan use the funds from its series-e+?
Alan plans to use the funds for: investment in technology and AI, international expansion, product improvements.